However, other investigations of CD73 in different solid tumors found contradictory results: CD73 has been reported as a disadvantageous prognostic or predictive factor, namely, in colorectal, gastric, gallbladder, prostate, and some forms of breast cancer [38–43]. This evidence concerns the gene NT5E and breast cancer.